HealthCare Africa News November 3, 2022

AFRICAN NEWS HEADLINES

South Africa’s health minister hopes for more pharma investments

SOUTH AFRICA?— Dr. Joe Phaahla, South Africa's health minister, has said that the country expects more investments in the pharmaceutical sector in the aftermath of the ravaging Covid-19 pandemic that shook its healthcare system. . .?Read More

USTDA grants Mobihealth US$67M to expand telemedicine infrastructure

NIGERIA?— Mobihealthcare Limited, a Nigeria-based telemedicine provider, has received US$67 million grant funding from the US Trade and Development Agency to determine the viability of expanding beyond Nigeria into four other African countries. . .?Read More

CS Susan N. Wafula takes the steering wheel at Afya House

KENYA?— Susan N. Wafula, the newly appointed Cabinet Secretary for Health, has taken over the ministry’s leadership with a promise to build on her predecessor's successes while improving in some areas in order to provide Kenyans with quality health services. . .Read More

AstraZeneca’s VP pushes for concerted efforts to reduce breast cancer burden

MENA?— Pelin Incesu, AstraZeneca’s Area Vice President for the Middle East and North Africa, is vouching for a concerted and sustained effort to reverse the region's growing breast cancer burden. . .Read More

Amref, J&J partner to train oncology nurses?

KENYA?—Amref Health Africa, and Johnson & Johnson in collaboration with Kenya’s Ministry of Health have partnered to implement measures to support remote teaching and learning to build the capacity of nurses in oncology nursing. . .?Read More

GLOBAL?NEWS HEADLINES

Thermo Fisher expands specialty diagnostics presence with The Binding Site buyout

USA?— Thermo Fisher Scientific has agreed to buy The Binding Site Group, a specialty diagnostics company, from a shareholder group led by European equity firm Nordic Capital in an all-cash deal worth US$2.6 billion. . .?Read More

Johnson & Johnson to acquire Abiomed

USA —Johnson & Johnson is set to spend US$16.6 billion to buy cardiovascular technology company Abiomed to strengthen its medical device division ahead of its planned spinoff in the last quarter of 2023. . .?Read More

EMA recommends new measures for JAK Inhibitors after confirming risks

NETHERLANDS?—The European Medicines Agency's (EMA) safety committee has recommended restricting the use of a class of oral Janus Kinase (JAK) inhibitors in certain high-risk patients unless no other treatment options are available following a safety review that began in February.?. .?Read More

WHO urges proper urban planning to end malaria spread

SWITZERLAND?— The World Health Organization (WHO) has launched the Urban health research agenda on World Cities Day 2022, a comprehensive strategy to assist cities in building better infrastructure that will help mitigate malaria disease burden?.?. .Read More

GSK barred from bulk drug purchasing program in China

CHINA?—GSK plc has been barred from participating in volume-based procurement tenders in Shanghai until April 29, 2024, after failing a good manufacturing practices (GMP) inspection at a contract manufacturing plant in Poland that makes products for China.?. .Read More